FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Testosterone 100 mg prolonged-release subcutaneous implant Count of base of active ingredient False un Inferred relationship Some
    Testosterone 100 mg prolonged-release subcutaneous implant Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Buprenorphine 20 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Buprenorphine 20 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Buprenorphine 10 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Hydrogen peroxide 350 mg/mL oropharyngeal solution Has concentration strength denominator value False un Inferred relationship Some 1
    Hydrogen peroxide 350 mg/mL oropharyngeal solution Count of base of active ingredient False un Inferred relationship Some
    Testosterone 200 mg prolonged-release subcutaneous implant Has presentation strength denominator value False un Inferred relationship Some 1
    Testosterone 200 mg prolonged-release subcutaneous implant Count of base of active ingredient False un Inferred relationship Some
    Dexamethasone 700 microgram prolonged-release ocular implant Has presentation strength denominator value False un Inferred relationship Some 1
    Dexamethasone 700 microgram prolonged-release ocular implant Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    méthylprednisolone 1 g, fiole de poudre pour injection Has presentation strength numerator value False un Inferred relationship Some 1
    méthylprednisolone 1 g, fiole de poudre pour injection Has presentation strength denominator value False un Inferred relationship Some 1
    méthylprednisolone 1 g, fiole de poudre pour injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Diclofenac potassium 50 mg powder for oral solution sachet Has presentation strength denominator value False un Inferred relationship Some 1
    Diclofenac potassium 50 mg powder for oral solution sachet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Varicella-zoster virus antibody 104 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Varicella-zoster virus antibody 104 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Heparin (as porcine heparin sodium) 100 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Heparin (as porcine heparin sodium) 100 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Interferon beta-1a 24 million unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Interferon beta-1a 24 million unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Heparin (as porcine heparin sodium) 10 unit/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Heparin (as porcine heparin sodium) 10 unit/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet Has presentation strength denominator value False un Inferred relationship Some 3
    Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3

    Start Previous Page 186 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start